81 FR 30544 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 81, Issue 95 (May 17, 2016)
National Institutes of Health
Federal Register Volume 81, Issue 95 (May 17, 2016)
| Page Range | 30544-30544 | |
| FR Document | 2016-11553 |
[Federal Register Volume 81, Number 95 (Tuesday, May 17, 2016)] [Notices] [Page 30544] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-11553] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Investigator Initiated Extended Clinical Trial (R01). Date: June 6, 2016. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health 3C100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Yong Gao, Ph.D., Scientific Review Officer Scientific Review Program, Division of Extramural Activities, Room #3G13B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Rockville, MD 20892-7616, (240) 669-5048, yong.[email protected]. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Investigator Initiated Extended Clinical Trial (R01). Date: June 6, 2016. Time: 2:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 3C100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Yong Gao, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3G13B, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Rockville, MD 20892-7616, (240) 669-5048, .[email protected]. Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group; Microbiology and Infectious Diseases Research Committee. Date: June 9-10, 2016. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3F100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Frank S. De Silva, Ph.D., Scientific Review Officer Scientific Review Program, Division of Extramural Activities, Room #3E72A, National Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9834, Bethesda, MD 20892934, (240) 669-5023, [email protected]. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Rapid Assessment of Zika Virus (ZIKV) Complications (R21). Date: June 13, 2016. Time: 9:30 a.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3C100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Uday K. Shankar, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room #3G21B, National Institutes of Health, NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, (240) 669-5051, [email protected]. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: May 11, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016-11553 Filed 5-16-16; 8:45 am] BILLING CODE 4140-01-P
![30544 Federal Register / Vol. 81, No. 95 / Tuesday, May 17, 2016 / Notices
obtained by contacting: Attn. Invention filed March 11, 2011 entitled, ‘‘Agonist/ Division of Extramural Activities, Room
Development and Marketing Unit, Antagonist Compositions and Methods #3G13B, National Institutes of Health/NIAID,
Technology Transfer Center, National of Use’’ (Pending). 5601 Fishers Lane, MSC 9823, Rockville, MD
Cancer Institute, 9609 Medical Center U.S. Patent Application 13/634,447 20892–7616, (240) 669–5048, yong.gao@
Drive, Mail Stop 9702, Rockville, MD (HHS Reference No. E–048–2010/0–US– nih.gov.
20850–9702, Tel. 240–276–5515 or 04) filed September 12, 2012 entitled, Name of Committee: National Institute of
email ncitechtransfer@mail.nih.gov. A ‘‘Agonist/Antagonist Compositions and Allergy and Infectious Diseases Special
signed Confidential Disclosure Methods of Use’’. Emphasis Panel; Investigator Initiated
Agreement may be required to receive U.S. Patent Application 15/010,830 Extended Clinical Trial (R01).
copies of the patent applications. (HHS Reference No. E–048–2010/0–US– Date: June 6, 2016.
SUPPLEMENTARY INFORMATION: 05) filed January 29, 2016 entitled, Time: 2:30 p.m. to 3:30 p.m.
Technology description follows. ‘‘Agonist/Antagonist Compositions and Agenda: To review and evaluate grant
Title of invention: Improved Pepper Methods of Use’’ (Pending). applications.
Spray for Repellency and Collaboration Opportunity: Place: National Institutes of Health, 3C100,
Incapacitation. Researchers at the NCI seek licensing for 5601 Fishers Lane, Rockville, MD 20892
Description of Technology: Non-lethal use as a non-lethal incapacitation agent. (Telephone Conference Call).
means of temporarily incapacitating a Contact Information: Requests for Contact Person: Yong Gao, Ph.D., Scientific
copies of the patent application or Review Officer, Scientific Review Program,
person are greatly needed for law
inquiries about licensing, research Division of Extramural Activities, Room
enforcement and for personal
collaborations, and co-development #3G13B, National Institutes of Health/NIAID,
protection. A common approach is to 5601 Fishers Lane, MSC 9823, Rockville, MD
use pepper spray. Although current opportunities should be sent to John D.
20892–7616, (240) 669–5048, .gao@nih.gov.
pepper sprays are effective, they cause Hewes, Ph.D., email: john.hewes@
nih.gov. Name of Committee: Microbiology,
pain for excessively long periods, and
Infectious Diseases and AIDS Initial Review
could be life threatening for people who Dated: May 11, 2016. Group; Microbiology and Infectious Diseases
suffer from asthma and have John D. Hewes, Research Committee.
hypersensitive airways. This technology Technology Transfer Specialist, Technology Date: June 9–10, 2016.
describes a composition for use in an Transfer Center, National Cancer Institute. Time: 12:00 p.m. to 5:00 p.m.
aerosol or spray, that when [FR Doc. 2016–11555 Filed 5–16–16; 8:45 am] Agenda: To review and evaluate grant
administered, causes a painful BILLING CODE 4140–01–P applications.
stimulation and incapacitates a person Place: National Institutes of Health, Room
for only a brief period. This technology 3F100, 5601 Fishers Lane, Rockville, MD
may improve safety over currently DEPARTMENT OF HEALTH AND 20892 (Telephone Conference Call).
available pepper sprays. HUMAN SERVICES Contact Person: Frank S. De Silva, Ph.D.,
Potential Commercial Applications: Scientific Review Officer Scientific Review
• Law enforcement (policing, riot National Institutes of Health Program, Division of Extramural Activities,
control, crowd control) Room #3E72A, National Institutes of Health/
• Incapacitating agent for use in National Institute of Allergy and NIAID, 5601 Fishers Lane, MSC 9834,
hostage situations Infectious Diseases; Notice of Closed Bethesda, MD 20892934, (240) 669–5023,
• Personal self-defense Meetings fdesilva@niaid.nih.gov.
Value Proposition: Name of Committee: National Institute of
• Incapacitating pepper spray with Pursuant to section 10(d) of the
Federal Advisory Committee Act, as Allergy and Infectious Diseases Special
reduced toxicity and enhanced safety. Emphasis Panel; Rapid Assessment of Zika
• May reduce potential agency amended (5 U.S.C. App.), notice is
Virus (ZIKV) Complications (R21).
liability in case of an adverse response hereby given of the following meetings.
The meetings will be closed to the Date: June 13, 2016.
of an individual who was sprayed (due Time: 9:30 a.m. to 4:30 p.m.
to reduced toxicity may not be as life public in accordance with the
Agenda: To review and evaluate grant
threatening to those suffering from provisions set forth in sections
applications.
asthma or have hypersensitive airways 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Place: National Institutes of Health, Room
as standard pepper sprays). as amended. The grant applications and 3C100, 5601 Fishers Lane, Rockville, MD
• Mixture can be incorporated into a the discussions could disclose 20892 (Telephone Conference Call).
spray, aerosol, or other dispersions. confidential trade secrets or commercial Contact Person: Uday K. Shankar, Ph.D.,
Development Stage: Basic (Target ID). property such as patentable material, Scientific Review Officer, Scientific Review
Inventor(s): Peter M. Blumberg (NCI), and personal information concerning Program, Division of Extramural Activities,
Larry V. Pearce (NCI). individuals associated with the grant Room #3G21B, National Institutes of Health,
Intellectual Property: applications, the disclosure of which NIAID, 5601 Fishers Lane, MSC 9823,
HHS Reference No. E–048–2010/0. would constitute a clearly unwarranted Bethesda, MD 20892–9823, (240) 669–5051,
U.S. Provisional Application 61/ invasion of personal privacy. uday.shankar@nih.gov.
340,063 (HHS Reference No. E–048– Name of Committee: National Institute of (Catalogue of Federal Domestic Assistance
2010/0–US–01) filed March 12, 2010 Allergy and Infectious Diseases Special Program Nos. 93.855, Allergy, Immunology,
entitled, ‘‘Improved Pepper Spray for Emphasis Panel; Investigator Initiated and Transplantation Research; 93.856,
Repellency and Incapacitation of People Extended Clinical Trial (R01). Microbiology and Infectious Diseases
Date: June 6, 2016.
jstallworth on DSK7TPTVN1PROD with NOTICES
and Animals’’. Research, National Institutes of Health, HHS)
PCT Application PCT/US2011/028132 Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant Dated: May 11, 2016.
(HHS Reference No. E–048–2010/0–
applications. Natasha M. Copeland,
PCT–02) filed March 11, 2011 entitled, Place: National Institutes of Health 3C100,
‘‘Agonist/Antagonist Compositions and Program Analyst, Office of Federal Advisory
5601 Fishers Lane, Rockville, MD 20892
Methods of Use’’. Committee Policy.
(Telephone Conference Call).
Canada: Application 2,792, 878 (HHS Contact Person: Yong Gao, Ph.D., Scientific [FR Doc. 2016–11553 Filed 5–16–16; 8:45 am]
Reference No. E–048–2010/0–CA–03) Review Officer Scientific Review Program, BILLING CODE 4140–01–P
VerDate Sep<11>2014 15:32 May 16, 2016 Jkt 238001 PO 00000 Frm 00030 Fmt 4703 Sfmt 9990 E:\FR\FM\17MYN1.SGM 17MYN1](https://thefederalregister.org/doc/81_FR_30639/page/1.svg)
Document Created: 2018-02-07 15:05:25
Document Modified: 2018-02-07 15:05:25
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | June 6, 2016. | |
| FR Citation | 81 FR 30544 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR